SCHEMBL18628002

SCHEMBL18628002

CC=Cc1ccccc1Oc1ccc(C(=CC)c2ccccc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.50
HTT P42858 5/20 0.49
ALDH1A1 P00352 4/20 0.44
HPGD P15428 3/20 0.44
LMNA P02545 7/20 0.44
KMT2A Q03164 3/20 0.44
TLR4 O00206 1/20 0.43
TLR2 O60603 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
L3MBTL1 Q9Y468 2/20 0.41
MAOB P27338 1/20 0.40
RAB9A P51151 2/20 0.40
NPC1 O15118 1/20 0.40
BCHE P06276 1/20 0.40
MAPT P10636 1/20 0.40
MEN1 O00255 2/20 0.39
PARP10 Q53GL7 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20386935 1.00 GAA (0.50) GAAHTTALDH1A1HPGDLMNA
SCHEMBL18628001 1.00 GAA (0.50) GAAHTTALDH1A1HPGDLMNA
SCHEMBL18628003 0.97 GAA (0.49) GAAHTTALDH1A1HPGDLMNA
SCHEMBL18656993 0.97 GAA (0.49) GAAHTTALDH1A1HPGDLMNA
SCHEMBL18628004 0.97 GAA (0.49) GAAHTTALDH1A1HPGDLMNA
SCHEMBL9504456 0.87 GAA (0.56) GAAHTTALDH1A1LMNAKMT2A
SCHEMBL9504448 0.87 GAA (0.56) GAAHTTALDH1A1LMNAKMT2A
SCHEMBL18628011 0.87 GAA (0.49) GAAHTTALDH1A1HPGDLMNA
SCHEMBL18628012 0.87 GAA (0.49) GAAHTTALDH1A1HPGDLMNA
SCHEMBL18656994 0.87 GAA (0.49) GAAHTTALDH1A1HPGDLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108349861-B Alkenylphenoxy-substituted 1, 1-diphenylethylenes, process for their preparation and their use 赢创运营有限公司 2021-07-20 CN disclosed
EP-3350150-B1 ALKENYLPHENOXY-SUBSTITUTED 1,1-DIPHENYLETHYLENES, PROCESSES FOR THEIR PREPARATION, AND THEIR USE EVONIK OPERATIONS GMBH (DE) 2020-02-19 EP disclosed
US-10233139-B2 Alkenylphenoxy-substituted 1,1-diphenylethylenes, processes for their preparation, and their use EVONIK TECHNOCHEMIE GMBH (DE) 2019-03-19 US disclosed
EP-3350150-A1 ALKENYLPHENOXY-SUBSTITUTED 1,1-DIPHENYLETHYLENES, PROCESSES FOR THEIR PREPARATION, AND THEIR USE Evonik Technochemie GmbH (DE) 2018-07-25 EP disclosed
US-20180201561-A1 ALKENYLPHENOXY-SUBSTITUTED 1,1-DIPHENYLETHYLENES, PROCESSES FOR THEIR PREPARATION, AND THEIR USE EVONIK TECHNOCHEMIE GMBH (DE) 2018-07-19 US disclosed
US-20180201561-A1 ALKENYLPHENOXY-SUBSTITUTED 1,1-DIPHENYLETHYLENES, PROCESSES FOR THEIR PREPARATION, AND THEIR USE EVONIK TECHNOCHEMIE GMBH (DE) 2018-07-19 US disclosed
WO-2017045932-A1 ALKENYLPHENOXY-SUBSTITUTED 1,1-DIPHENYLETHYLENES, PROCESSES FOR THEIR PREPARATION, AND THEIR USE EVONIK TECHNOCHEMIE GMBH (DE) 2017-03-23 WO disclosed
EP-3144290-A1 ALKENYLPHENOXY-SUBSTITUTED 1,1-DIPHENYLETHYLENES, PROCESSES FOR THEIR PREPARATION, AND THEIR USE Evonik Technochemie GmbH (DE) 2017-03-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180201561-A1 ALKENYLPHENOXY-SUBSTITUTED 1,1-DIPHENYLETHYLENES, PROCESSES FOR THEIR PREPARATION, AND THEIR USE MACF1, COL1A1, PLOD1 GAA 4566/4885HTT 2585/4885ALDH1A1 261/4885
US-10233139-B2 Alkenylphenoxy-substituted 1,1-diphenylethylenes, processes for their preparation, and their use MACF1, COL1A1, PLOD1 GAA 4535/4885HTT 1894/4885ALDH1A1 292/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.